SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026177
Filing Date
2021-11-10
Accepted
2021-11-10 16:36:42
Documents
51
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20210930_10q.htm   iXBRL 10-Q 782801
2 EXHIBIT 31.1 CERTIFICATION OF CO-CEOS ex_284992.htm EX-31.1 13555
3 EXHIBIT 31.2 CERTIFICATION OF CFO ex_284993.htm EX-31.2 15595
4 EXHIBIT 32.1 CERTIFICATION OF CO-CEOS PURSUANT TO 18 USC ex_284994.htm EX-32.1 9511
5 EXHIBIT 32.2 CERTIFICATION OF CFO PURSUANT TO 18 USC ex_284995.htm EX-32.2 7363
  Complete submission text file 0001437749-21-026177.txt   4268554

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA inbp-20210930.xsd EX-101.SCH 38497
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20210930_cal.xml EX-101.CAL 39936
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20210930_def.xml EX-101.DEF 275887
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20210930_lab.xml EX-101.LAB 242755
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20210930_pre.xml EX-101.PRE 291942
11 EXTRACTED XBRL INSTANCE DOCUMENT inbp20210930_10q_htm.xml XML 652805
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 211397270
SIC: 2834 Pharmaceutical Preparations